News

Business Wire8mon
Sonoma Biotherapeutics Receives $45 Million Milestone Payment from Regeneron under Ongoing Collaboration
SOUTH SAN FRANCISCO, Calif. & SEATTLE--(BUSINESS WIRE)--Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (T reg) therapies for ...
Yahoo Finance17d
Sonoma Biotherapeutics Appoints Rajesh Krishnan, Ph.D., as Chief Technical Officer
SOUTH SAN FRANCISCO, Calif. & SEATTLE, May 13, 2025--(BUSINESS WIRE)--Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg ...
Business Wire2y
Sonoma Biotherapeutics Expands Board of Directors with Appointments of Katina Dorton, J.D., MBA, and John Davis, M.D., MPH
SOUTH SAN FRANCISCO, Calif. & SEATTLE--(BUSINESS WIRE)--Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (T reg) therapies for ...
FierceBiotech2y
Sonoma takes 'a big bite' with $120M Regeneron Treg collab, tacking on up to 5 new targets
Regulatory T cell-focused Sonoma Biotherapeutics has been following a slow and steady path ever since bringing in a whopping $265 million in a 2021 fundraising round, one of the largest of the year.
Hosted on MSN8mon
Seattle’s Sonoma Biotherapeutics receives $45M milestone payment
Sonoma Biotherapeutics on Wednesday announced that it received a $45 million payment from Regeneron Pharmaceuticals for meeting a significant milestone in its efforts to research, develop and ...
Yahoo Finance24d
Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
SOUTH SAN FRANCISCO, Calif. & SEATTLE, May 06, 2025--(BUSINESS WIRE)--Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg ...
PMLiVE2y
Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
Regeneron and Sonoma Biotherapeutics have announced a partnership to identify and develop regulatory T cell (Treg) therapies for autoimmune diseases. Treg cells work by surveying the body for unwanted ...
Business Insider2y
Regeneron Partners With Sonoma Biotherapeutics To Develop T Cell Therapies
(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) and Sonoma Biotherapeutics, Inc. Tuesday announced partnership to discover, develop and sell T cell therapies for autoimmune diseases. As per the ...
Morningstar17d
Sonoma Biotherapeutics Appoints Rajesh Krishnan, Ph.D., as Chief Technical Officer
Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced the ...
Morningstar24d
Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting Sonoma Biotherapeutics, Inc., a clinical-stage ...
The Bakersfield Californian17d
Sonoma Biotherapeutics Appoints Rajesh Krishnan, Ph.D., as Chief Technical Officer
SOUTH SAN FRANCISCO, Calif. & SEATTLE-- (BUSINESS WIRE)--May 13, 2025-- ...
The Bakersfield Californian24d
Sonoma Biotherapeutics Announces Oral and Poster Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, will be sharing oral and ...